| The clinical approach toward giant cell tumor of bone L Van der Heijden, PDS Dijkstra, MAJ van de Sande, JR Kroep, RA Nout, ... The oncologist 19 (5), 550-561, 2014 | 276 | 2014 |
| Giant cell tumour of bone in the denosumab era L van der Heijden, PDS Dijkstra, JY Blay, H Gelderblom European Journal of Cancer 77, 75-83, 2017 | 151 | 2017 |
| Giant cell tumor with pathologic fracture: should we curette or resect? L van der Heijden, PDS Dijkstra, DA Campanacci, CLMH Gibbons, ... Clinical Orthopaedics and Related Research® 471 (3), 820-829, 2013 | 114 | 2013 |
| The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis) L Van der Heijden, C Gibbons, PDS Dijkstra, JR Kroep, CSP Van Rijswijk, ... The Journal of Bone & Joint Surgery British Volume 94 (7), 882-888, 2012 | 93 | 2012 |
| A multidisciplinary approach to giant cell tumors of tendon sheath and synovium—a critical appraisal of literature and treatment proposal L van der Heijden, CLMH Gibbons, AB Hassan, JR Kroep, H Gelderblom, ... Journal of surgical oncology 107 (4), 433-445, 2013 | 76 | 2013 |
| Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones: a retrospective study of 93 patients L van der Heijden, MA Van de Sande, PD Dijkstra Acta Orthopaedica 83 (4), 401-405, 2012 | 67 | 2012 |
| Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers L van der Heijden, ICM van der Geest, HWB Schreuder, ... JBJS 96 (5), e35, 2014 | 63 | 2014 |
| Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis? L van der Heijden, MAJ van de Sande, AC Heineken, M Fiocco, ... JBJS 95 (21), e159, 2013 | 63 | 2013 |
| Functional outcome and quality of life after the surgical treatment for diffuse-type giant-cell tumour around the knee: a retrospective analysis of 30 patients L Van der Heijden, MJL Mastboom, PDS Dijkstra, MAJ van de Sande The bone & joint journal 96 (8), 1111-1118, 2014 | 62 | 2014 |
| Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients L van der Heijden, SR Piner, MAJ van de Sande International orthopaedics 40, 2459-2468, 2016 | 42 | 2016 |
| Giant cell tumours of the small bones of the hands and feet: long-term results of 30 patients and a systematic literature review VC Oliveira, L Van der Heijden, ICM Van Der Geest, DA Campanacci, ... The bone & joint journal 95 (6), 838-845, 2013 | 42 | 2013 |
| Current concepts in the treatment of giant cell tumour of bone L van der Heijden, S Dijkstra, M van de Sande, H Gelderblom Current opinion in oncology 32 (4), 332-338, 2020 | 35 | 2020 |
| Giant cell tumors of the sacrum—a nationwide study on midterm results in 26 patients after intralesional excision L Van der Heijden, MAJ van de Sande, ICM van der Geest, ... European Spine Journal 23, 1949-1962, 2014 | 30 | 2014 |
| Adjuvant zoledronic acid in high‐risk giant cell tumor of bone: a multicenter randomized phase II trial A Lipplaa, JR Kroep, L van der Heijden, PC Jutte, PCW Hogendoorn, ... The oncologist 24 (7), 889-e421, 2019 | 24 | 2019 |
| Updated concepts in treatment of giant cell tumor of bone L van der Heijden, A Lipplaa, K van Langevelde, JVMG Bovée, ... Current opinion in oncology 34 (4), 371-378, 2022 | 19 | 2022 |
| Neoadjuvant denosumab for extensive giant cell tumor in os ischium—a case report L Heijden, MAJ Sande, PCW Hogendoorn, H Gelderblom, PDS Dijkstra Acta Orthopaedica 86 (3), 393-395, 2015 | 19 | 2015 |
| Management of tenosynovial giant cell tumour of the foot and ankle G Spierenburg, ST Lancaster, L van der Heijden, MJL Mastboom, ... The Bone & Joint Journal 103 (4), 788-794, 2021 | 14 | 2021 |
| Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches G Spierenburg, L van der Heijden, K van Langevelde, K Szuhai, ... Expert Opinion on Therapeutic Targets 26 (4), 333-345, 2022 | 10 | 2022 |
| Surgical management of 144 diffuse‐type TGCT patients in a single institution: A 20‐year cohort study G Spierenburg, L van der Heijden, MJL Mastboom, K van Langevelde, ... Journal of Surgical Oncology 126 (6), 1087-1095, 2022 | 9 | 2022 |
| Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT G Spierenburg, P Grimison, C Chevreau, S Stacchiotti, ... European Journal of Cancer 173, 219-228, 2022 | 8 | 2022 |
Michiel van de Sandeprofessor of orthopedic oncology Leiden University medical center and princes maxima center forVerified email at lumc.nl
